Cincinnati, OH, United States of America

Amal Assa'ad

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2010.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:

goldMedal1 out of 834,411 
Other
 patents

Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Amal Assa'ad: Innovator in Genetic Markers of Food Allergy

Introduction

Amal Assa'ad is a prominent inventor based in Cincinnati, OH (US). She has made significant contributions to the field of genetics, particularly in understanding food allergies. Her innovative work has led to the development of a genetic marker that can help identify individuals at risk for food allergies.

Latest Patents

Amal Assa'ad holds a patent for "Genetic markers of food allergy." This patent discloses a genetic marker that comprises variants of IL-4 receptor alpha, IL13, and CD14. This groundbreaking discovery has the potential to transform how food allergies are diagnosed and managed.

Career Highlights

Throughout her career, Amal has focused on the intersection of genetics and immunology. Her research has been instrumental in advancing the understanding of food allergies, paving the way for new diagnostic tools and therapeutic approaches. With 1 patent to her name, she continues to be a valuable asset in her field.

Collaborations

Amal has collaborated with notable professionals in her field, including Gurjit K Khurana Hershey and Ranajit Chakraborty. These collaborations have enriched her research and contributed to the advancement of knowledge in food allergy genetics.

Conclusion

Amal Assa'ad's work in genetic markers for food allergies represents a significant advancement in the field of genetics. Her innovative contributions are paving the way for improved diagnosis and treatment options for individuals with food allergies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…